Kavitha Ranganathan Selected Research

Bronchiolitis Obliterans

10/2009

Cytomegalovirus immunoglobulin decreases the risk of cytomegalovirus infection but not disease after pediatric lung transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kavitha Ranganathan Research Topics

Disease

13	Wounds and Injuries (Trauma) 01/2024 - 01/2015
10	Burns 04/2024 - 01/2015
9	Heterotopic Ossification (Ectopic Ossification) 01/2019 - 06/2015
4	Breast Neoplasms (Breast Cancer) 11/2023 - 10/2015
3	Infections 01/2018 - 10/2009
2	Neoplasms (Cancer) 10/2022 - 03/2018
2	Hypoxia (Hypoxemia) 01/2019 - 02/2015
2	Cleft Lip (Harelip) 01/2019 - 10/2016
2	Myositis Ossificans (Fibrodysplasia Ossificans Progressiva) 01/2017 - 01/2017
2	Fibrosis (Cirrhosis) 12/2016 - 12/2016
1	Confusion (Bewilderment) 07/2023
1	Feminization 07/2023
1	Prostatic Neoplasms (Prostate Cancer) 10/2022
1	Mandibular Fractures 01/2021
1	Wrist Fractures 10/2020
1	Necrosis 01/2019
1	Cleft Palate (Palate, Cleft) 01/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Edema (Dropsy) 01/2018
1	Muscular Atrophy (Muscle Atrophy) 12/2016
1	Atherosclerosis 12/2016
1	Hand Injuries (Hand Injury) 11/2016
1	Type 2 Diabetes Mellitus (MODY) 12/2015
1	Traumatic Brain Injuries (Traumatic Brain Injury) 07/2015
1	Spinal Cord Injuries (Spinal Cord Injury) 07/2015
1	Craniosynostoses (Craniosynostosis) 01/2014
1	Cytomegalovirus Infections (Inclusion Disease) 10/2009
1	Bronchiolitis Obliterans 10/2009
1	Virus Diseases (Viral Diseases) 10/2009
1	Viremia 10/2009

Drug/Important Bio-Agent (IBA)

3	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2017 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 02/2015
1	AT 112IBA 10/2022
1	Guanosine Diphosphate (GDP)IBA 12/2021
1	CollagenIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2019
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	IronIBA 01/2019
1	Amifostine (Ethyol)FDA LinkGeneric 03/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	CytokinesIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2017
1	Bone Morphogenetic Protein ReceptorsIBA 01/2017
1	Sirolimus (Rapamycin)FDA Link 12/2016
1	Aggrecans (Aggrecan)IBA 12/2016
1	LigandsIBA 12/2016
1	Activins (Activin)IBA 01/2016
1	LeptinIBA 12/2015
1	AllodermIBA 10/2015
1	FlexHDIBA 10/2015
1	MicronutrientsIBA 07/2015
1	Oxygen (Dioxygen)IBA 07/2015
1	Insulin-Like PeptidesIBA 06/2015
1	Vascular Endothelial Growth Factor BIBA 02/2015
1	Messenger RNA (mRNA)IBA 02/2015
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2015
1	Hematoxylin (Haematoxylon)IBA 01/2015
1	salicylhydroxamic acid (SHAM)IBA 01/2015
1	Immunoglobulins (Immunoglobulin)IBA 10/2009
1	Ganciclovir (Cytovene)FDA LinkGeneric 10/2009
1	GlobulinsIBA 10/2009
1	cytomegalovirus-specific hyperimmune globulinIBA 10/2009

Therapy/Procedure

7	Tenotomy 01/2018 - 06/2015
3	Therapeutics 01/2021 - 02/2015
2	Mastectomy (Mammectomy) 11/2023 - 07/2023
2	Reoperation 01/2019 - 10/2016
2	Radiotherapy 01/2019 - 03/2018
2	Mammaplasty (Breast Reconstruction) 01/2018 - 10/2015
2	Operative Surgical Procedures 08/2015 - 02/2015
2	Arthroplasty 07/2015 - 06/2015
1	Perioperative Period 04/2024
1	Continuity of Patient Care 01/2024
1	Sex Reassignment Surgery 07/2023
1	Surgical Amputation (Amputations) 10/2020
1	Intravenous Administration 03/2018
1	Prostheses and Implants (Prosthesis) 01/2018
1	Antibiotic Prophylaxis 01/2018
1	Cell Transplantation 12/2016
1	Aftercare (After-Treatment) 11/2016
1	Subcutaneous Injections 01/2015
1	Blood Transfusion (Blood Transfusions) 01/2014
1	Lung Transplantation 10/2009